Unity Biotechnology, Inc. Cash and Cash Equivalents
Unity Biotechnology, Inc. had Cash and Cash Equivalents of $8.00 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-04-22
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $8.00M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $7.58M.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $8.90M.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $7.58M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-03-31 | $8.00M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $7.58M 10-Q · filed 2025-04-22 |
| 2024-09-30 | $8.90M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $7.58M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $7.43M 10-Q · filed 2025-04-22 |
| 2023-12-31 | $19.80M 10-K · filed 2025-03-07 |
| 2023-09-30 | $7.88M 10-Q · filed 2024-11-04 |
| 2023-06-30 | $19.12M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $22.97M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $12.74M 10-K · filed 2025-03-07 |
| 2022-09-30 | $22.58M 10-K · filed 2024-04-15 |
| 2022-06-30 | $19.44M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $16.45M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $32.91M 10-K · filed 2024-04-15 |
| 2021-09-30 | $21.99M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $13.50M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $26.84M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $17.81M 10-K · filed 2023-03-15 |
| 2020-09-30 | $48.58M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $39.59M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $25.06M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $37.47M 10-K · filed 2022-03-15 |
| 2019-09-30 | $36.77M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $23.11M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $34.25M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $15.40M 10-K · filed 2021-03-23 |
| 2018-09-30 | $28.90M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $34.16M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $62.75M 10-Q · filed 2018-06-07 |
| 2017-12-31 | $7.30M 10-K · filed 2020-03-11 |
| 2016-12-31 | $89.29M 10-K · filed 2019-03-06 |